K Pharma Stock

K Pharma EBITDA per Employee

The EBITDA per Employee of K Pharma (4896.T) as of Aug 13, 2026 is -70.47 M JPY. In the previous year, EBITDA per Employee was -64.33 M JPY — a change of 9.53% (lower).

EBITDA per Employee

-70.47 MJPY

YoY

9.53%

Last updated:

EBITDA per Employee of K Pharma is 2026 -70.47 M JPY. EBITDA per Employee of K Pharma was 2025 -64.33 M JPY. It decreases by 9.53% lower compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

K Pharma Stock analysis

What does K Pharma do? K Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about K Pharma stock

EBITDA per Employee of K Pharma is -70.47 M JPY in 2026.

EBITDA per Employee of K Pharma changed from -64.33 M JPY to -70.47 M JPY, representing a 9.53% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee K Pharma since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's K Pharma historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Workforce — K Pharma

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — K Pharma